Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kai-Guo Li"'
Autor:
Zhong-Guo Liang, Fan Zhang, Ye Li, Ling Li, Song Qu, Fang Su, Bin-Bin Yu, Ying Guan, Lu Han, Kai-Guo Li, Xiao-Dong Zhu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveThe present study aimed to evaluate the role of integrating the pretreatment neutrophil-to-lymphocyte ratio (NLR) into the eighth edition of the AJCC staging system for nasopharynx cancer in an endemic region.MethodsBetween May 2007 and Dece
Externí odkaz:
https://doaj.org/article/d2df60f517454c6a84996da508552901
Autor:
Fan Zhang, Bin-Bin Yu, Lu Han, Zhong-Guo Liang, Fang Su, Ye Li, Ying Guan, Ling Li, Xiao-Dong Zhu, Kai-Guo Li, Song Qu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectiveThe present study aimed to evaluate the role of integrating the pretreatment neutrophil-to-lymphocyte ratio (NLR) into the eighth edition of the AJCC staging system for nasopharynx cancer in an endemic region.MethodsBetween May 2007 and Dece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::771325427279e7bbc21176e5dfdd0454
https://doi.org/10.3389/fonc.2021.724467
https://doi.org/10.3389/fonc.2021.724467
Publikováno v:
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences, Vol 8 (2021)
Frontiers in Molecular Biosciences, Vol 8 (2021)
Annexin A3 (ANXA3), also known as lipocortin III and placental anticoagulant protein III, has been reported to be dysregulated in tumor tissues and cancer cell lines, and harbors pronounced diagnostic and prognostic value for certain malignancies, su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5fd9f1229897106aa2ed35898d53a4
http://europepmc.org/articles/PMC8329414
http://europepmc.org/articles/PMC8329414
Autor:
Zhong-Guo Liang, Kai-Guo Li, Xin-Bin Pan, Hui-Ling Meng, Xiao-Hui Yang, Ling Li, Fanyan Zeng, Xiao-Yu Li, Song Qu, Xiao-Dong Zhu
Publikováno v:
Cancer Management and Research. 11:10651-10656
Background and aim Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Southern China, Southeast Asia. Radiotherapy is the main treatment for NPC. Still, about 20% of patients with NPC have a recurrence. No effective serum biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffcda21ab93a3e7839734372580ab6de
https://doi.org/10.2147/cmar.s218030
https://doi.org/10.2147/cmar.s218030
Autor:
Xianwei Mo, Chunhua Wu, Shi-Xiong Liang, Wei-Zhong Tang, Jun-Bao Wei, Song Qu, Jiansi Chen, Xiao-Hui Yang, Kai-Guo Li
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
This study aimed to evaluate whether the addition of oxaliplatin to a neoadjuvant chemoradiotherapy (CRT) regimen could improve survival benefit in locally advanced rectal cancer (LARC) patients. We retrospectively analysed 73 LARC patients (cT2-4 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c68ed55cac1e138eff80e332eb763715
https://doi.org/10.1038/s41598-020-69573-z
https://doi.org/10.1038/s41598-020-69573-z
Autor:
Kai-Guo Li, Shi-Ting Huang, Zhong-Guo Liang, Xiao-Hui Yang, Fang Su, Ling Li, Ruiling Ning, Xiao-Dong Zhu, Song Qu, Fanyan Zeng
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Serum microRNAs (miRNAs) have been reported as novel biomarkers for various diseases. But circulating biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma (NPC) have not been used in clinical practice. To screen out of different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234e5af7023992c00a30a5073fe6e93a
http://europepmc.org/articles/PMC7083955
http://europepmc.org/articles/PMC7083955
Autor:
Luo Huang, Adelene Y.L. Sim, Zhong-Guo Liang, Ying Wang, You-Qin Du, Hong Qi Tan, Xiaolei Shu, Enya H.W. Ong, Joseph Wee, Kai-Guo Li, Yue Xie, Xiao-Dong Zhu, Melvin L.K. Chua, Yongzhong Wu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in LDH level between chemotherapy (CT) cycles are associated with tumour re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e12ac7f617d4b4903faa6c0caf5fd9bf
https://doi.org/10.1177/1758835920970050
https://doi.org/10.1177/1758835920970050